Page 22 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In U11248 Today - Breaking & Trending Today
More than half of women treated with chemotherapy for localized breast cancer reported persistent amenorrhea at year 4 after diagnosis, according to a French study. ....
Differences in outcomes and quality of life across commonly used treatments for endocrine-refractory and triple-negative metastatic breast cancer were "razor-thin," leaving cost as a key factor. ....
Advocates who have been calling for reforms in the accelerated approvals process are concerned that Congress may avoid this issue while finalizing a major FDA law. ....
The relative newcomer to the field, ripretinib, was compared to standard second-line treatment with sunitinib in patients with advanced gastrointestinal stromal tumors. ....